TABLE 3.
Threshold | Sensitivity | Specificity | LR+ | LR– | PPV | NPV |
---|---|---|---|---|---|---|
(nmol/L) | [95% CI] | [95% CI] | [95% CI] | [95% CI] | [95% CI] | [95% CI] |
RR | ||||||
700.0 | 81.8% | 82.2% | 4.6 | .22 | 36.0% | 97.4% |
[48.2-97.7] | [72.7-89.5] | [2.7-7.8] | [.06-.78] | [18.0-57.5] | [90.8-99.7] | |
744.0 | 90.9% | 73.3% | 3.4 | .12 | 29.4% | 98.5% |
[58.7-99.8] | [63.0-82.1] | [2.3-5.0] | [.02-.81] | [15.1-47.5] | [92.0-100] | |
757.5 | 100% | 70.0% | 3.3 | .00 | 29.0% | 100% |
[71.5-100] | [59.4-79.2] | [2.4-4.6] | [.00-.00] | [15.4-45.9] | [94.3-100] | |
Day 1 | ||||||
465.5 | 70.6% | 82.4% | 4.0 | .36 | 35.3% | 95.4% |
[44.0-89.7] | [74.6-88.6] | [2.5-6.5] | [.17-.75] | [19.8-53.5] | [89.5-98.5] | |
469.0 | 76.5% | 81.6% | 4.2 | .29 | 36.1% | 96.2% |
[50.1-93.2] | [73.7-88.0] | [2.6-6.5] | [.12-.68] | [20.8-53.8] | [90.6-99.0] | |
576.5 | 88.2% | 70.4% | 3.0 | .17 | 28.9% | 97.8% |
[63.6-98.5] | [61.6-78.2] | [2.2-4.1] | [.05-.62] | [17.1-43.1] | [92.2-99.7] | |
Day 2 | ||||||
385.5 | 76.9% | 75.4% | 3.1 | .31 | 26.3% | 96.6% |
[46.2-95.0] | [66.5-83.0] | [2.0-4.9] | [.11-.83] | [13.4-43.1] | [90.5-99.3] | |
416.5 | 84.6% | 69.3% | 2.8 | .22 | 23.9% | 97.5% |
[54.6-98.1] | [60.0-77.6] | [1.9-4.0] | [.06-.80] | [12.6-38.8] | [91.4-99.7] | |
440.5 | 92.3% | 66.7% | 2.8 | .12 | 24.0% | 98.7% |
[64.0-99.8] | [57.2-75.2] | [2.0-3.8] | [.02-.76] | [13.1-38.2] | [93.0-100] | |
Day 3 | ||||||
257.5 | 54.6% | 89.6% | 5.2 | .51 | 46.2% | 92.3% |
[23.4-83.3] | [79.7-95.7] | [2.2-12.6] | [.26-.97] | [19.2-74.9] | [83.0-97.5] | |
273.5 | 63.6% | 88.1% | 5.3 | .41 | 46.7% | 93.7% |
[30.8-89.1] | [77.8-94.7] | [2.4-11.7] | [.19-.91] | [21.3-73.4] | [84.5-98.2] | |
329.0 | 72.7% | 82.1% | 4.1 | .33 | 40.0% | 94.8% |
[39.0-94.0] | [70.8-90.4] | [2.2-7.6] | [.13-.88] | [19.1-64.0] | [85.6-98.9] |
CI, confidence interval; LR+, positive likelihood ratio; LR–, negative likelihood ratio; NPV, negative predictive value; PPV, positive predictive value; RR, recovery room.
The likelihood ratios refer to patients in the hypocortisolism group. The PPV also refers to patients in the hypocortisolism group.